The countries investing most aggressively in algae-based chemical technologies are the United States, China, India, Japan, France, Spain, Germany, Australia, and Saudi Arabia. The global pattern is clear: Asia accounts for about 97% of world algae production, while Europe and the United States are concentrating on higher-value bioproducts, biorefineries, and scale-up infrastructure. That makes the sector a mix of large production bases and high-value innovation hubs rather than a single-country market.
The United States is one of the most active investors because federal agencies continue to fund algae R&D for fuels, chemicals, and low-carbon products. In 2024, the U.S. Department of Energy announced $20.2 million for 10 projects to advance mixed algae for biofuels and bioproducts, and in 2025 it signaled further support through the planned MASY program to improve affordable algae system yield. This shows the U.S. is still treating algae as a strategic platform for bioproducts and industrial decarbonization.
India and Japan are also investing heavily, but with a more biomanufacturing-oriented approach. In India, DBT-BIRAC has active 2025 calls for biomanufacturing, functional foods, carbon capture, and smart proteins, and BIRAC-supported algae firms are already commercializing algal DHA using industrial standards. Japan is building algae capability through NEDO and related national programs; its microalgae platforms focus on CO₂ fixation, high-value ingredients, and integrated biorefineries, including projects to produce useful substances from microalgae.
In Europe, the strongest country-level activity is in France, Spain, and Germany. A 2025 review of the European microalgal sector found 146 microalgae-derived products from 66 producers, with France leading spirulina production, followed by Italy and Spain; it also noted that Spain has the most microalgae companies overall, with Germany close behind. The European Commission’s algae initiative and related funding have made the EU a major commercialization zone for nutraceuticals, cosmetics, and sustainable bioproducts.
Outside the main blocs, Australia and Saudi Arabia stand out as fast-rising investors. Australia continues to back algae biotechnology through research funding and commercial startups, while Saudi Arabia has moved from interest to execution: the DABKSA program is a joint project with the Ministry of Environment, Water and Agriculture, and it targets a 100,000-hectare microalgal biomass development pathway for feed and related applications. In practice, these countries are investing where algae fit national goals for food security, carbon use, and bioeconomy diversification.
